Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Undifferentiated Pleomorphic Sarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00410462
What this trial is testing

Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma

Who this might be right for
Ovarian CancerSarcomaSmall Intestine Cancer
European Organisation for Research and Treatment of Cancer - EORTC 118
Testing effectiveness (Phase 2)Study completedNCT03277924
What this trial is testing

Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas

Who this might be right for
Soft Tissue SarcomaBone Sarcoma
Grupo Espanol de Investigacion en Sarcomas 197
Testing effectiveness (Phase 2)Study completedNCT00041236
What this trial is testing

Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 39
Testing effectiveness (Phase 2)Study completedNCT02500797
What this trial is testing

Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery

Who this might be right for
Locally Advanced Bone SarcomaLocally Advanced Dedifferentiated LiposarcomaLocally Advanced Gastrointestinal Stromal Tumor+18 more
National Cancer Institute (NCI) 164
Testing effectiveness (Phase 2)Study completedNCT00474994
What this trial is testing

Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas

Who this might be right for
Adult Malignant Fibrous Histiocytoma of BoneDesmoid TumorEndometrial Cancer+3 more
Memorial Sloan Kettering Cancer Center 53
Early research (Phase 1)Ended earlyNCT03670069
What this trial is testing

Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas

Who this might be right for
Metastatic LeiomyosarcomaMetastatic Synovial SarcomaMetastatic Undifferentiated Pleomorphic Sarcoma+15 more
Fred Hutchinson Cancer Center 27
Testing effectiveness (Phase 2)Study completedNCT02584309
What this trial is testing

Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma, Soft TissueSoft Tissue SarcomaUndifferentiated Pleomorphic Sarcoma+8 more
Washington University School of Medicine 73
Early research (Phase 1)Ended earlyNCT05827614
What this trial is testing

Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications

Who this might be right for
Triple Negative Breast Cancer (TNBC)High Grade Serous Ovarian CarcinomaHigh Grade Endometrial Carcinoma+9 more
Boundless Bio, Inc. 85
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07802652
What this trial is testing

Doxorubicin With or Without DT-7012 in Advanced Soft Tissue Sarcoma

Who this might be right for
Undifferentiated Pleomorphic Sarcoma (UPS)Dedifferentiated Liposarcoma (DDLPS)
Gustave Roussy, Cancer Campus, Grand Paris 80
Early research (Phase 1)Study completedNCT00720174
What this trial is testing

Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma

Who this might be right for
Adult AngiosarcomaAdult Desmoplastic Small Round Cell TumorAdult Epithelioid Sarcoma+32 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)WithdrawnNCT05116800
What this trial is testing

Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma

Who this might be right for
Soft Tissue SarcomaUndifferentiated Pleomorphic SarcomaMyxofibrosarcoma+10 more
Brown University
Testing effectiveness (Phase 2)Looking for participantsNCT05182164
What this trial is testing

Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas

Who this might be right for
Soft Tissue Sarcoma AdultAdvanced Soft-tissue SarcomaEwing Sarcoma+2 more
Institut Bergonié 119
Testing effectiveness (Phase 2)UnknownNCT05193214
What this trial is testing

A Phase II Study for 609A in the Treatment of Advanced Undifferentiated Pleomorphic Sarcoma

Who this might be right for
Sarcoma, Soft Tissue
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 30
Testing effectiveness (Phase 2)UnknownNCT04480502
What this trial is testing

ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma

Who this might be right for
Undifferentiated Pleomorphic SarcomaMyxofibrosarcoma
Tracon Pharmaceuticals Inc. 207
Early research (Phase 1)Study completedNCT03009201
What this trial is testing

Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery

Who this might be right for
Advanced Soft Tissue SarcomaLocally Advanced AngiosarcomaLocally Advanced Leiomyosarcoma+24 more
OHSU Knight Cancer Institute 16
Large-scale testing (Phase 3)Study completedNCT00003212
What this trial is testing

Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 780
Testing effectiveness (Phase 2)Study completedNCT00064220
What this trial is testing

Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma
Daiichi Sankyo
Large-scale testing (Phase 3)Ended earlyNCT01189253
What this trial is testing

Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 133
Early research (Phase 1)Looking for participantsNCT05607095
What this trial is testing

LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma

Who this might be right for
Uveal MelanomaMelanomaMetastatic Uveal Melanoma+1 more
Memorial Sloan Kettering Cancer Center 40
Early research (Phase 1)Ended earlyNCT04099277
What this trial is testing

LY3435151 in Participants With Solid Tumors

Who this might be right for
Solid TumorTriple-negative Breast CancerGastric Adenocarcinoma+6 more
Eli Lilly and Company 2
Next Page